Just simply getting old, from age 50 to 75, increased risk for Alzheimer’s disease by 100-fold, which really dwarfed 10-fold ...

A large-scale study has revealed the impact of germline variants on proteins in 10 cancer types. Scientists from the National ...

As pharma deals with the impact of U.S. NIH grant cuts and the imposition of tariffs, a lot of pressure is shifting to ...

AMT Medical BV raised $25 million in a series B financing round for its Excimer Laser Assisted Non-Occlusive Anastomosis ...

The BioWorld Biopharmaceutical Index reached a first quarter (Q1) peak of 9.64% by the end of February, before closing March ...

Named after Swiss mountains, Granite Bio AG emerged from stealth with $70 million in funds through a series B to advance two ...

They are not zombies, they are fallen angels.” That is view of Nick Johnston, a U.K-based banker who has come up with a new ...

The U.S. Department of Justice recently announced the formation of a task force that will advocate the roll-back of regulations that affect a wide swath of sectors of the American economy. Health care ...

Akeso Inc. scored U.S. FDA approval of the PD-1 monoclonal antibody penpulimab in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or ...

It’s time for the U.S. Congress to finally put some guardrails on the 340B prescription drug discount program it created more than 30 years ago as a way to help fund health care for low-income ...

Synthetic lethality specialist Tessellate Bio NV has closed its first deal, agreeing to a €500 million-plus (US$570 million) ...

(α7nAChRs), expressed in neurons and astrocytes at lower levels, have been implicated in neuroinflammatory and ...